药物介导的神经免疫调节在精神病/心理不良事件中
Sandra I Marques1, Susana I Sá2, Helena Carmo1
1UCIBIO - Applied Molecular Biosciences Unit, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Progress in neuro-psychopharmacology & biological psychiatry
|August 7, 2024
概括
药物可以通过影响神经免疫路径引起精神和心理不良事件 (PPAE). 了解这些药物诱导的神经炎症机制对于预测和预防PPAEs至关重要.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 免疫学 免疫学 免疫学
背景情况:
- 药物可以诱导精神和心理不良事件 (PPAE).
- 人们对PPAE背后的机制知之甚少,这阻碍了早期检测.
- 神经免疫调节越来越被认为是PPAEs的一个关键因素.
研究的目的:
- 审查PPAEs导致的神经免疫调节机制的最新进展.
- 探索特定药品和PPAEs之间的关联.
- 突出针对PPAE的潜在有针对性的干预措施.
主要方法:
- 关于神经免疫调节和PPAEs的综合文献综述.
- 对针对神经炎症和大脑平衡的药物机制的分析.
- 检查外周免疫系统调节对大脑的影响.
主要成果:
- 强有力的证据支持神经免疫调节和PPAEs之间的联系.
- 药物可以通过直接向途径 (例如,胆固醇,血清系统) 影响大脑炎症.
- 不能穿越血脑屏障的药物也可以通过改变周围免疫力来诱导PPAE.
结论:
- 神经免疫调节在药物诱导的PPAE中起着重要作用.
- 了解这些途径可以在药物开发过程中改善PPAE预测.
- 针对神经炎症途径为PPAE干预提供了潜在的潜力.
更多相关视频
相关概念视频
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


